dc.contributor.author |
Palau González, Vanesa |
dc.contributor.author |
Riera, Marta |
dc.contributor.author |
Soler, María José |
dc.date.accessioned |
2021-10-26T05:58:25Z |
dc.date.available |
2021-10-26T05:58:25Z |
dc.date.issued |
2020 |
dc.identifier.citation |
Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 |
dc.identifier.issn |
0931-0509 |
dc.identifier.uri |
http://hdl.handle.net/10230/48810 |
dc.format.mimetype |
application/pdf |
dc.language.iso |
eng |
dc.publisher |
Oxford University Press |
dc.relation.ispartof |
Nephrol Dial Transplant. 2020;35(6):1071-2 |
dc.rights |
© Oxford University Press. This is a pre-copyedited, author-produced version of an article accepted for publication in Nephrology, dialysis, transplantation following peer review. The version of record Palau V, Riera M, Soler MJ. ADAM17 inhibition may exert a protective effect on COVID-19. Nephrol Dial Transplant. 2020;35(6):1071-2. DOI: 10.1093/ndt/gfaa093 is available online at: http://dx.doi.org/10.1093/ndt/gfaa093 |
dc.title |
ADAM17 inhibition may exert a protective effect on COVID-19 |
dc.type |
info:eu-repo/semantics/article |
dc.identifier.doi |
http://dx.doi.org/10.1093/ndt/gfaa093 |
dc.subject.keyword |
covid-19 |
dc.rights.accessRights |
info:eu-repo/semantics/openAccess |
dc.type.version |
info:eu-repo/semantics/acceptedVersion |